Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sudo Biosciences logo — Developing precision TYK2 therapeutics.

Sudo Biosciences

Developing precision TYK2 therapeutics.

Founded 2020 United States Carmel, United States 27 employees Series B Total: $67.00M Biopharma, Biotechnology +2

General Information

Company Name Sudo Biosciences
Founded Year 2020
Location United States Carmel, United States
Employees 27
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series B
Business Model B2B, B2C, B2D
Revenue Model Licensing, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Sudo Biosciences. To contact Sudo Biosciences, visit sudobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sudo Biosciences compare?

A PDF of Sudo Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sudo Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sudo Biosciences

Sudo Biosciences, founded in 2020 and headquartered in the United States, is a burgeoning force in the biopharmaceutical sector. With a focused mission encapsulated by its slogan, "Developing precision TYK2 therapeutics," the company is committed to delivering innovative, best-in-class medicines aimed at transforming patients’ lives.

The company zeroes in on the tyrosine kinase 2 (TYK2) pseudokinase domain, a critical component in cytokine signaling pathways linked to various immune-mediated inflammatory conditions. This targeted approach places Sudo Biosciences at the forefront of addressing unmet medical needs in diseases driven by dysregulated immune responses.

The company's progress and potential did not go unnoticed in the investment community, securing a $30.00M Series B investment on 01 January 2024. Esteemed investors, including Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises, back this venture, signifying strong confidence in its innovative pursuits.

Business keywords: Biopharmaceutical, Precision Therapeutics, TYK2 Pseudokinase Domain, Cytokine Signaling, Immune-Mediated Inflammatory Conditions, Multiple Sclerosis, Neurodegenerative Diseases, Brain-Penetrant Therapeutics, Neuroinflammation, Topical Candidate, Dermatologic Diseases, Next-Generation Inhibitors, Drug Development, Novel Medicines, Patient-Centric Healthcare

Services & Products

Development of first and best-in-class medicines
Therapies for neurological and immunological diseases
Drug design and optimization
Clinical trial management

Target Customers

Patients with serious neurological conditions Patients with immune-mediated inflammatory conditions Healthcare providers and institutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $30.00M 3
Dementia Discovery Fund Leaps by Bayer
Dementia Discovery Fund, Leaps by Bayer +1
01 Jan 2024
Series A $37.00M 2
Frazier Healthcare Partners Velosity Capital
Frazier Healthcare Partners, Velosity Capital
01 Sep 2022

Sudo Biosciences Alternatives & Competitors

View All Alternatives
Sudo Biosciences vs
BIORCHESTRA Co., Ltd.
BIORCHESTRA Co., Ltd. United States

We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift for neurod...

Series C
16 employees
Biopharma, Biotechnology
Compare Sudo Biosciences vs BIORCHESTRA Co., Ltd.
Sudo Biosciences vs
ACELYRIN, INC.
ACELYRIN, INC. United States

We are a late-stage clinical biopharma company focused on providing life-changing new treatment opti...

Acquired
103 employees
Biopharma, Biotechnology
Compare Sudo Biosciences vs ACELYRIN, INC.
Sudo Biosciences vs
Biogen
Biogen United States

Innovative therapies worldwide for people living with serious neurological and neurodegenerative dis...

IPO
7823 employees
Biotechnology, Health Care
Also compare with: Sudo Biosciences vs Alumis Alumis View all alternatives

FAQ About Sudo Biosciences

Developing precision TYK2 therapeutics.
Sudo Biosciences was founded in 2020.
Sudo Biosciences is headquartered in Carmel, United States.
Sudo Biosciences operates in Biopharma, Biotechnology, Health Care and Life Sciences. Its work centres on Biopharmaceutical, Precision Therapeutics, TYK2 Pseudokinase Domain and Cytokine Signaling. Its customers include Patients with serious neurological conditions, Patients with immune-mediated inflammatory conditions and Healthcare providers and institutions.
Sudo Biosciences has a B2B, B2C and B2D business model. Its revenue comes from Licensing and Product Sales.
Sudo Biosciences has approximately 27 employees.
Sudo Biosciences has completed 2 funding rounds, raising a total of $67.00M. The latest funding stage is Series B.
Sudo Biosciences offers: Development of first and best-in-class medicines, Therapies for neurological and immunological diseases, Drug design and optimization, Clinical trial management.
Top alternatives and competitors to Sudo Biosciences include BIORCHESTRA Co., Ltd., ACELYRIN, INC., Biogen, 3T Biosciences, Alumis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sudo Biosciences and BIORCHESTRA Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sudo Biosciences, https://bouncewatch.com/company/sudo-biosciences, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes